Elevated serum interleukin-18 level is associated with all-cause mortality in stable hemodialysis patients independently of cardiac dysfunction

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Liu, Yen Wen ^a   Su, Chi Ting ^b   Chang, Yu Tzu ^a   Tsai, Wei Chuan ^a   Su, Yu Ru ^c   Wang, Saprina P H ^c   Yang, Chun Shin ^d   Tsai, Liang Miin ^a   Chen, Jyh Hong ^a   Sung, Junne Ming ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d Catholic Fu An Hospital   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 18 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; BLOOD; HEART LEFT VENTRICLE HYPERTROPHY; HOSPITALIZATION; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; RENAL REPLACEMENT THERAPY;

AGED; FEMALE; HOSPITALIZATION; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INTERLEUKIN-18; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; ROC CURVE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84897139038     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089457     Document Type: Article

References (45)

1. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, et al. (2008) All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 371:2173-2182.
2. deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, et al. (2003) Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 290:353-359.
3. Yang WC, Hwang SJ (2008) Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance. Nephrol Dial Transplant 23:3977-3982.
4. Wong CK, Szeto CC, Chan MH, Leung CB, Li PK,et al. (2007) Elevation of pro-inflammatory cytokines, C-reactive protein and cardiac troponin T in chronic renal failure patients on dialysis. Immunol Invest 36:47-57. (Pubitemid 46024915)
5. Zoccali C, Tripepi G, Mallamaci F (2006) Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients? J Am Soc Nephrol 17 (Suppl 3):S169-S173. (Pubitemid 44865244)
6. Tripepi G, Mallamaci F, Zoccali C (2005) Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 16 (Suppl 1):S83-S88. (Pubitemid 41725091)
7. Chiang CK, Hsu SP, Pai MF, Peng YS, Ho TI, et al. (2004) Interleukin-18 is a strong predictor of hospitalization in haemodialysis patients. Nephrol Dial Transplant 19:2810-2815.
8. Yano A, Nakao K, Sarai A, Akagi S, Kihara T, et al. (2005) Elevated serum interleukin-18 levels might reflect the high risk of hospitalization in patients on peritoneal dialysis. Nephrology (Carlton) 10:576-582. (Pubitemid 41801837)
9. Mallat Z, Corbaz A, Scoazec A, Besnard S, Lesèche G, et al. (2001) Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 104:1598-1603. (Pubitemid 32947520)
10. Whitman SC, Ravisankar P, Daugherty A (2002) Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon gamma. Circ Res 90:E34-E38.
11. Gerdes N, Sukhova GK, Libby P, Reynolds RS, Young JL, et al. (2002) Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 195:245-257. (Pubitemid 34461268)
12. Blankenberg S, Luc G, Ducimetière P, Arveiler D, Ferrières J, et al. (2003) Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 108:2453-2459. (Pubitemid 37444405)
13. Xing SS, Bi XP, Tan HW, Zhang Y, Xing QC, et al. (2010) Overexpression of interleukin-18 aggravates cardiac fibrosis and diastolic dysfunction in fructose-fed rats. Mol Med 16:465-470.
14. Woldbaek PR, Sande JB, Stromme TA, Lunde PK, Djurovic S, et al. (2005) Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice. Am J Physiol Heart Circ Physiol.;289:H708-H714. (Pubitemid 41129387)
15. Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, et al. (2002) Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106:24-30. (Pubitemid 34747437)
16. Wang AY, Lam CW, Yu CM, Wang M, Chan IH, et al. (2006) Troponin T, left ventricular mass, and function are excellent predictors of cardiovascular congestion in peritoneal dialysis. Kidney Int 70:444-452. (Pubitemid 44141570)
17. Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, et al. (2006) Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T. Heart 92:804-809. (Pubitemid 43799216)
18. Goicoechea M, de Vinuesa SG, Gomez-Campdera F, Luno J (2005) Predictive cardiovascular risk factors in patients with chronic kidney disease (CKD). Kidney Int Suppl 93:S35-S38. (Pubitemid 40019213)
19. Edwards NC, Hirth A, Ferro CJ, Townend JN, Steeds RP (2008) Subclinical abnormalities of left ventricular myocardial deformation in early-stage chronic kidney disease: the precursor of uremic cardiomyopathy? J Am Soc Echocardiogr 21:1293-1298.
20. Wang J, Khoury DS, Yue Y, Torre-Amione G, Nagueh SF (2008) Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur Heart J 29:1283-1289. (Pubitemid 351768130)
21. Liu YW, Tsai WC, Su CT, Lin CC, Chen JH (2009) Evidence of left ventricular systolic dysfunction detected by automated function imaging in patients with heart failure and preserved left ventricular ejection fraction. J Card Fail 15:782-789.
22. Liu YW, Su CT, Huang YY, Yang CS, Huang JW, et al. (2011) Left ventricular systolic strain in chronic kidney disease and hemodialysis patients. Am J Nephrol 33:84-90.
23. Stanton T, Leano R, Marwick TH (2009) Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring. Circ Cardiovasc Imaging 2:356-364
24. Liu YW, Su CT, Sung JM, Wang SP, Su YR, et al. (2013) Association of left ventricular longitudinal strain with mortality among stable hemodialysis patients with preserved left ventricular ejection fraction. Clin J Am Soc Nephrol 26:1564-1574.
25. Su CT, Liu YW, Lin JW, Chen SI, Yang CS, et al. (2012) Increased Procollagen Type I C-Terminal Peptide Levels Indicate Diastolic Dysfunction in End-Stage Renal Disease Patients Undergoing Maintenance Dialysis Therapy. J Am Soc Echocardiogr 25:895-901.
26. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, et al. (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440-1463.
27. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, et al. (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107-133.
28. Yashiro M, Kamata T, Yamadori N, Tomita M, Muso E (2007) Evaluation of markers to estimate volume status in hemodialysis patients: atrial natriuretic peptide, inferior vena cava diameter, blood volume changes and filtration coefficients of microvasculature. Ther Apher Dial 11:131-137. (Pubitemid 46449872)
29. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, et al. (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23:685-713; quiz 786-788.
30. Ando Y, Yanagiba S, Asano Y (1995) The inferior vena cava diameter as a marker of dry weight in chronic hemodialyzed patients. Artif Organs 19:1237-1242. (Pubitemid 26167345)
31. Yingchoncharoen T, Agarwal S, Popović ZB, Marwick TH (2013) Normal ranges of left ventricular strain: a meta-analysis. J Am Soc Ehocardiogr 26:185-191.
32. Akdag I, Yilmaz Y, Kahvecioglu S, Bolca N, Ercan I, et al. (2008) Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study. Nephron Clin Pract 108:c99-c105. (Pubitemid 351346932)
33. Owen WF, Jr., Lew NL, Liu Y, Lowrie EG, Lazarus JM (1993) The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329:1001-1006. (Pubitemid 23307908)
34. Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ (1998) Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 31:997-1006. (Pubitemid 28265197)
35. Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM (1999) Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. Kidney Int 55:1945-1951. (Pubitemid 29197983)
36. Vanholder R, Van Laecke S, Glorieux G (2008) What is new in uremic toxicity? Pediatr Nephrol 23:1211-1221.
37. Yamagami H, Kitagawa K, Hoshi T, Furukado S, Hougaku H, et al. (2005) Associations of serum IL-18 levels with carotid intima-media thickness. Arterioscler Thromb Vasc Biol 25:1458-1462. (Pubitemid 40923368)
38. Wang M, Markel T, Crisostomo P, Herring C, Meldrum KK, et al. (2007) Deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1beta. Am J Physiol Heart Circ Physiol 292:H1694-H1699. (Pubitemid 46572390)
39. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, et al. (1998) Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-150. (Pubitemid 28361303)
40. Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KS, et al. (1999) Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med 27:1309-1318. (Pubitemid 29379369)
41. Li S, Jiao X, Tao L, Liu H, Cao Y, et al. (2007) Tumor necrosis factor-alpha in mechanic trauma plasma mediates cardiomyocyte apoptosis. Am J Physiol Heart Circ Physiol 293:H1847-H1852. (Pubitemid 47367234)
42. Liao X, Liu JM, Du L, Tang A, Shang Y, et al. (2006) Nitric oxide signaling in stretch-induced apoptosis of neonatal rat cardiomyocytes. FASEB J 20:1883-1885.
43. Konopleva M, Zhao S, Xie Z, Segall H, Younes A, et al. (1999) Apoptosis. Molecules and mechanisms. Adv Exp Med Biol 457:217-236.
44. Reddy VS, Harskamp RE, van Ginkel MW, Calhoon J, Baisden CE, et al. (2008) Interleukin-18 stimulates fibronectin expression in primary human cardiac fibroblasts via PI3K-Akt-dependent NF-kappaB activation. J Cell Physiol 215:697-707. (Pubitemid 351632691)
45. Chandrasekar B, Mummidi S, Claycomb WC, Mestril R, Nemer M (2005) Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes. J Biol Chem 280:4553-4567. (Pubitemid 40288623)